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INTRODUCTION
Breast	cancer	(BC)	is	the	second	leading	cause	of	cancer	
death	in	women	in	Greece	as	well	as	in	the	Western	European	
Countries	and	United	States	[1,2].	Risk	biomarkers	with	a	life-
time	accepted	positive	predictive	value	for	BC	are	limited	to	
individuals	with	mutation	in	genes	responsible	for	hereditary	
breast	cancer	(HBC),	lobular	carcinoma	in	situ	or	atypical	hy-
perplasia.	Thus,	the	vast	majority	of	women	interested	in	risk	
assessment	would	not	qualify	for	genetic	testing	nor	have	
they	undergone	a	diagnostic	biopsy	for	precancerous	lesion	
detection	[3].	Moreover,	physical	examination	and	mammo-
graphic	imaging	remain	the	only	currently	acceptable	meth-
ods	for	investigation	of	breast	lesions.	Therefore,	several	early	
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Objective:	Ductal	lavage	(DL)	involves	evaluation	of	the	ductal	system	of	the	breast	for	detection	of	intra-ductal	carcinomas	and	
precursor	lesions	by	collecting	breast	epithelial	cells	using	a	small-gauge	catheter	inserted	into	a	ductal	orifice	on	the	nipple.	
The	aim	of	this	survey	was	to	analyze	cytologic	features	of	samples	obtained	from	low-risk	women	with	DL	and	to	elucidate	the	
efficacy	of	this	diagnostic	modality	in	evaluating	fluid	production,	cannulating	and	determining	atypical	breast	epithelial	cells.
Methods: Into	this	prospective	study	were	consecutively	registered	80	women	between	ages	28	to	67.	Nipple	aspiration	was	
performed	to	identify	all	fluid-yielding	ducts.	According	to	the	grading	of	specific	features	the	interpretation	of	the	sample	
included:	normal/benign	(category,	0),	mild	atypical	(category,	I),	markedly	atypical	(category,	II)	or	malignant	(category,	III)	
disorders.
Results:	Ninety	five	percent	(316/334)	of	the	nipple	aspirate	fluid	samples	were	classified	as	category	0,	4.8%	(16/334)	as	
category	I	and	0.2%	(2/334)	as	category	II	changes.	Category	III	disorders	were	not	detected.	Therefore,	in	80%	of	the	women	
examined	results	were	within	normal	limits	while	17.5%	of	the	participants	presented	mild	atypical	and	2.5%	markedly	atypical	
rates.
Conclusion: DL	collection	procedure	proved	to	be	rapid	as	well	as	acceptable	by	the	women	studied.	It	retains	the	advantage	
over	other	methods	of	nipple	aspirate	fluid	in	that	it	is	easy	to	perform,	thereby	removing	most	clinician	variability.	It	also	
helped	low	risk	women	to	discriminate	those	with	breast	disorders	that	require	additional	investigation,	further	follow-up	or	
administration	of	preventive	medication.
Keywords:	Breast	neoplasms,	Cytology,	Ductal	lavage,	Nipple	aspirate	fluid	
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stage	neoplastic	disorders	cannot	be	elucidated,	especially	if	
they	arise	in	densely	fibrotic	breast	tissue.	Thus,	there	is	an	im-
mense	interest	in	developing	new	methods	for	BC	screening	
that	would	allow	prompt	detection	of	neoplasms	as	well	as	
precancerous	lesions	[4].
It	is	well	known	that	the	majority	of	BCs	originate	in	the	epi-
thelium	of	the	breast	ducts.	Recent	investigations	support	that	
most	lesions	are	slow	growing	and	progress	from	precancer-
ous	cells,	which	present	cellular	and	nuclear	changes	that	can	
be	identified	microscopically	[5].	Evidence	of	precancerous	
lesions	-	ductal	epithelial	atypia/atypical	ductal	hyperplasia	
(ADH)	-	has	been	correlated	significantly	with	future	BC	devel-
opment.	Ductal	lavage	(DL)	involves	evaluation	of	the	ductal	
system	of	the	breast	for	detection	of	intra-ductal	carcinomas	
and	precursor	lesions	(ADH)	by	collecting	breast	epithelial	
cells	from	the	lining	of	the	ducts,	using	a	small-gauge	cath-
eter	inserted	into	a	ductal	orifice	on	the	nipple,	permitting	
direct	access	to	exfoliated	breast	duct	epithelial	cells	[6,7].	The	
majority	of	nipple	aspirate	fluid	(NAF)	studies	estimating	DL	
procedure	were	conducted	in	increased	genetic	risk	women	
[8].	The	aim	of	this	survey	was	to	analyze	cytologic	features	
of	samples	obtained	from	low-risk	women	with	DL	and	to	
elucidate	the	efficacy	of	this	diagnostic	modality	in	evaluating	
fluid	production,	cannulating	and	determining	atypical	breast	
epithelial	cells	in	this	population.
MATERIALS AND METHODS 
Into	this	prospective	study	were	consecutively	registered	
80	women	between	ages	28	to	67	years	old	who	attended	
the	Breast	Clinic	of	our	university	hospital	from	01/06/06	to	
30/06/09.	The	Institutional	Review	Board	approved	the	study,	
but	since	written	consent	was	obtained	in	each	case	no	Ethi-
cal	Committee	approval	was	necessary.	Gail	risk	profile	calcu-
lated	at	enrolment	was	used	to	characterise	women	as	low	
risk.	Exclusion	criteria	included:	Gail	risk	≥1.7%,	pregnancy	or	
lactation	within	6	months	of	enrolment,	identification	of	BC,	
ovarian	cancer,	history	of	ductal	carcinoma	in	situ,	breast	irra-
diation,	prior	chemotherapy,	allergy	to	xylocaine,	peri-areolar	
breast	surgery	which	might	disrupt	the	ductal	system	of	the	
breast,	a	breast	implant	or	prior	silicone	injections	and	active	
infection	or	inflammation	in	the	breast.	Additional	candidates	
who	did	not	attend	both	pre-	and	post-DL	clinic	visits	were	
excluded	from	the	analysis	(n=11).	Standard	preparation	of	
the	breast,	including	topical	anaesthetic	cream	applied	to	the	
nipple/areola	60	minutes	prior	to	the	procedure,	was	pro-
vided	to	all	DL	participants.	The	nipple/areolar	complex	sur-
face	was	gently	probed	with	a	micro	dilator	tip	prior	to	DL	to	
confirm	adequate	anaesthesia.	In	women	who	reported	pain,	
additional	topical	anaesthesia	and/or	subcutaneous	injections	
of	xylocaine	around	the	base	of	the	nipple	were	administered.	
Nipple	aspiration	was	performed	to	identify	all	fluid-yielding	
ducts.	We	attempted	to	reveal	and	cannulate	all	visible	ducts,	
regardless	of	NAF	status.	After	successful	catheter	inser-
tion,	3-5	mL	of	2%	xylocaine	was	infused,	followed	by	20	mL	
of	sterile	normal	saline,	whenever	possible.	The	breast	was	
massaged	to	facilitate	recovery	of	the	DL	fluid	into	the	cath-
eter	collection	chamber.	An	average	of	5	mL	was	collected	
per	duct	and	the	lavage	fluid	was	preserved	in	CytoLyt	and	
stained	by	a	standard	Papanicolaou	technique.	This	prepara-
tion	maximized	cell	recovery	and	preservation	along	with	
direct	comparison	with	nipple	aspirate.	DL	was	performed	by	
one	clinician	and	the	preparation	of	the	breast	through	the	
completion	of	the	procedure	required	approximately	an	hour	
for	each	studied	breast.	The	location	of	each	lavaged	duct	
was	recorded	in	a	standard	scheme	and	stored	in	the	partici-
pant's	permanent	medical	record.	All	suitable	DL	specimens	
were	screened	by	a	cytologist	experienced	in	the	evaluation	
of	NAFs.	According	to	the	grading	of	specific	features	(cell	ar-
rangement,	size,	variation,	nuclear	characteristics,	nucleoli	and	
background	findings	as	nonepithelial	cells,	microcalcifications	
and	necrosis)	the	interpretation	of	the	sample	included:	nor-
mal/benign	(category	0),	mild	atypical	(category	I),	markedly	
atypical	(category	II)	or	malignant	(category	III)	disorders	[9,10].
RESULTS
During	the	study	period	80	women	(n=80)	were	successfully	
enrolled	and	334	ducts	were	examined	by	DL	(mean	number	
of	ducts	per	person,	4.1).	Overall	characteristics	of	the	study	
participants	are	summarized	in	Table	1.	Average	age	was	
45.81	years	(range,	28	to	67	years).	There	was	no	significant	
difference	between	age	and	fluid	production	while	32	women	
Table 1. Characteristics of study participants
                Characteristics Values
No. of patients 80
Age (yr, range) 28-67
Premenopausal  44
Postmenopausal  22
Perimenopausal  14
No. of 5 year Gail risk (range) 0.5-1.6
   <1.1% 42
   ≥1.1%  38Ioanna Konstandiadou, et al.
http://dx.doi.org/10.3802/jgo.2012.23.2.110 112 www.ejgo.org
(40%)	proved	fluid	producers.	Furthermore,	55%	of	women	
with	a	lactation	history	produced	NAF	while	25%	of	partici-
pants	who	never	lactated	were	fluid	producers.	Mean	Gail	risk	
index	was	1.1%	(Table	2).	
Final	cytology	results	of	the	334	available	for	evaluation	
specimens	are	summarized	in	Table	3.	In	case	of	multiple	NAF	
values,	the	most	abnormal	was	taken	into	consideration.	Nine-
ty	five	percent	(316/334)	of	the	NAF	samples	were	classified	
as	category	0,	4.8%	(16/334)	as	category	I	and	0.2%	(2/334)	as	
category	II	changes.	Category	III	disorders	were	not	detected.	
Therefore,	in	80%	of	the	women	examined	results	were	within	
normal	limits	while	17.5%	of	the	participants	presented	mild	
atypical	and	2.5%	markedly	atypical	rates.	A	total	of	62	women	
(70%)	were	surveyed	for	procedure	acceptance	three	weeks	
after	the	intervention.	The	average	immediate	postoperative	
comfort	assessment	rating	was	6	on	a	scale	of	1-10	(one	being	
most	comfortable).	The	nipple,	areola,	and	breast	areas	were	
visually	assessed	immediately	following	the	procedure.	Major	
adverse	events	were	not	reported.	DL	was	accomplished	in	all	
participants.	Minor	events	including	bleeding	or	small	surface	
lacerations	were	apparent	in	two	cases.	These	were	treated	
with	topical	ointment	and	meticulous	observation,	and	all	
symptoms	resolved	without	further	intervention.	Eighty-three	
percent	of	the	participants	declared	that	they	would	repeat	
the	DL	procedure.	
The	16	women	presented	with	category	I-II	changes	were	re-
ferred	again	to	the	breast	clinic	of	our	institution	for	further	ex-
amination.	Concerning	those	with	category	I	changes	(n=14),	
they	were	informed	that	hyperplasia	is	considered	to	be	a	
physiological	response	to	a	specific	stimulus,	while	the	cells	
of	a	hyperplastic	growth	remain	subject	to	normal	regulatory	
control	mechanisms.	Their	appearance	in	the	breast	may	be	
attributed	to	several	causes,	including	increased	demand	(e.g.,	
proliferation	of	basal	layer	of	epidermis	to	compensate	skin	
loss),	chronic	inflammatory	response,	hormonal	dysfunctions,	
or	compensation	for	damage	or	disease	elsewhere.	It	was	
also	noted	that	many	authors	support	that	hyperplasia	is	the	
earliest	precursor	for	the	development	of	breast	premalignant	
changes,	and	this	is	something	that	is	to	be	clarified	in	the	fu-
ture.	Thus,	it	was	explained	that	there	was	no	need	for	further	
investigation	and	all	women	returned	to	their	annual	follow-
up	program.
For	the	two	women	(2.5%)	with	atypical	hyperplasia	a	more	
detailed	explanation	included	information	that	ADH	is	a	defi-
nitely	benign	lesion	of	the	breast	that	indicates	an	increased	
risk	of	BC.	Since	a	thorough	evaluation	was	conducted	and	
imaging	results	were	within	normal	ranges,	a	follow-up	pro-
gramme	of	mammograms	and	physician	appointment	every	
6	months	was	implemented.	Follow-up	information	was	ob-
tained	for	the	next	3	years	and	all	women	with	atypical	hyper-
plasia	remained	asymptomatic	[11].
DISCUSSION
In	accordance	with	recent	surveys	atypical	hyperplasia	of	
the	breast	ductal	epithelium	is	associated	with	an	increased	
risk	of	subsequent	development	of	BC	[12-15].	In	this	prospec-
tive	study	we	report	cytologic	examination	of	NAF	samples	
collected	from	otherwise	asymptomatic	healthy	women	with	
DL.	We	suggest	that	it	is	technically	feasible	to	detect	normal	
as	well	as	atypical	breast	ductal	epithelial	cells	using	routine	
cytologic	preparation	methods,	even	in	low	risk	women.	We	
also	observed	that	75%	of	the	participants	had	adequate	cel-
lularity	(defined	as	greater	than	10	ductal	epithelial	cells	pres-
ent)	which	is	similar	to	other	studies	that	recorded	cytology	
results,	the	mean	number	of	ducts	cannulated	per	person	was	
4,	and	only	11	nipples	could	not	be	examined	as	a	result	of	
incomplete	catheterization.	Nevertheless,	women	in	whom	la-
vage	specimens	had	inadequate	cellularity	were	not	excluded	
from	this	analysis.	Thus	all	included	participants	provided	at	
Table 2. Atypia rate by calculated Gail risk (n=80)
5-Year Gail risk  Normal/benign Mild atypia Marked atypia Malignant
Total 64 (80) 14 (17.5) 2 (2.5) -
<1.1% 30 (37.5) 11 (13.7) 1 (1.25) -
≥1.1% 34 (42.5) 3 (3.75) 1 (1.25) -
Values are presented as number (%).
Table 3. Final cytology results
                 Variables No. (%)
Cannulated ducts (mean per person) 334 (4.1)
Right ducts   162 (48.5)
Left ducts   172 (51.5)
Inability to cannulate ducts  30 (8.2)
Ductal acellular specimens   24 (7.2)
Fluid producing ducts   133 (40)
Dry ducts   201 (60)Ductal lavage in breast cancer
J Gynecol Oncol Vol. 23, No. 2:110-114 www.ejgo.org 113
least	one	adequate	specimen.
Nipple	aspiration,	the	former	type	of	collecting	nipple	fluid,	is	
characterized	by	the	advantage	of	being	a	non-invasive,	well	
tolerated,	easy	to	perform	and	inexpensive	route	for	evaluat-
ing	breast	epithelium.	Its	significance	is	limited	by	the	small	
amounts	of	aspirate	available	for	analysis,	the	relatively	low	
cellular	yield,	and	the	fact	that	a	number	of	women	are	not	
fluid	yielders.	DL,	despite	its	invasiveness,	produces	material	
that	is	much	more	cellular	than	NAF	that	allows	duct	specific	
sampling.	This	method	of	obtaining	breast	ductal	epithelial	
cells	can	be	quickly	performed	in	an	office	setting;	patients	
do	not	need	to	be	referred	to	a	specialist	and	can	potentially	
have	the	procedure	by	trained	non-physician	staff	[16,17].	
The	current	study	highlights	the	same	limitations	described	
to	other	studies	of	DL	or	nipple	fluid	cytology.	All	women	
included	in	the	study	were	visiting	a	breast	clinic	and	the	ma-
jority	presented	with	breast	symptoms	for	evaluation,	mainly	
atypical	pain.	The	ethnic	make-up	of	this	cohort	was	predomi-
nantly	white	and	therefore	the	associated	relative	risks	may	
not	be	applicable	to	other	ethnicities	with	varying	physiologic	
factors,	influencing	breast	epithelium.	Moreover,	only	2/4	of	
the	collecting	ducts	were	sampled	so	it	is	essential	to	realize	
that	only	a	small	proportion	of	the	ductal	system	of	the	breast	
is	sampled	by	DL.	As	early	detection	of	BC	is	critical	for	prompt	
cure,	being	able	to	identify	women	at	high	risk	for	neoplastic	
transformation	would	justify	closer	follow-up	and	the	imple-
mentation	of	multiple	methods	to	ensure	early	detection.	NAF	
examination	may	enhance	current	risk	prediction	models	and	
provide	a	convenient	and	inexpensive	way	to	help	screening	
individuals	at	increased	risk	for	BC	[18-20].
The	DL	procedure	has	been	reported	to	be	a	feasible	way	
to	obtain	NAF	samples	for	cytological	assessment	and	there	
are	clear	advantages	to	using	it	over	manual	collection	tech-
niques.	Information	regarding	proliferative	breast	epithelium	
is	currently	obtained	for	use	in	the	Gail	model	via	biopsy,	an	
invasive	screening	tool	for	large	populations	of	women.	Nev-
ertheless,	the	obligatory	use	of	biopsy	for	Gail	model	defini-
tion	is	not	implemented	as	relevant	reference	about	potential	
previous	invasive	procedure	consists	essential	information	
during	Gail	model	specification	process.	Breast	biopsies	are	
performed	once	a	woman	is	symptomatic,	limiting	their	abil-
ity	to	provide	predictive	value	in	determining	who	is	at	risk	
for	BC.	On	the	other	hand,	NAF	assessment	is	not	a	diagnostic	
test	for	BC	detection.	NAF	production	and	cytological	assess-
ment	may	be	used	in	conjunction	with	the	Gail	model	for	
risk	prediction.	Despite	the	absence	of	significant	association	
between	our	cytology	findings	and	patients'	Gail	score,	cy-
tological	variation	indicative	of	increased	risk	of	BC	develop-
ment	provides	essential	contribution	in	discriminating	low	risk	
women	with	malignant	potential.	Our	experience	suggests	
that	DL	has	yielded	enough	numbers	of	exfoliated	epithelial	
cells	to	permit	reliable	cytological	diagnosis	or	to	support	fur-
ther	research	activities.	Therefore,	it	is	likely	to	play	a	pivotal	
role	in	BC	screening	protocols.	
Overall,	the	DL	collection	procedure	was	proved	to	be	rapid	
as	well	as	acceptable	by	the	women	studied	as	it	posed	little	
physical	risk.	It	retains	the	advantage	over	other	methods	
of	NAF	in	that	it	is	easy	to	perform,	thereby	removing	most	
clinician	variability.	Despite	the	limited	sample	and	restricted	
follow-up	time	it	also	helped	low	risk	women	to	discriminate	
those	with	breast	disorders	that	require	additional	investiga-
tion,	further	follow-up	or	administration	of	preventive	medi-
cation.	Nevertheless	future	studies	are	necessary	to	explain	
the	association	between	our	findings	and	increased	BC	risk.	
It	is	also	necessary	to	test	breast	fluids	for	specific	biomarkers	
indicative	of	malignancy	related	to	genomic	and	proteomic	
analysis	in	order	to	further	the	research	on	etiologic	factors	
involved	in	breast	carcinogenesis	and	BC	prevention	[21].
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